Rapid Dose Therapeutics Corp. (CSE: DOSE)
Canada
· Delayed Price · Currency is CAD 0.240
0.00 (0.00%)
Dec 3, 2024, 4:00 PM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 515.92K CAD in the quarter ending August 31, 2024, with 46.08% growth. This brings the company's revenue in the last twelve months to 1.34M, up 20.09% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.34M
Revenue Growth
+20.09%
P/S Ratio
18.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.82M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.51B |
| Trulieve Cannabis Corp. | 1.58B |
| Cresco Labs Inc. | 981.27M |
| Grown Rogue International Inc. | 28.83M |
| Planet 13 Holdings Inc. | 147.38M |
| Ayr Wellness Inc. | 627.53M |
| Jushi Holdings Inc. | 350.48M |
| MariMed Inc. | 213.26M |